Patents by Inventor Eugene J. McNally

Eugene J. McNally has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF
    Publication number: 20240197818
    Abstract: Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Application
    Filed: February 28, 2024
    Publication date: June 20, 2024
    Inventors: Sidney L. WEISS, Ashim K. MITRA, Eugene J. MCNALLY
  • Topical cyclosporine-containing formulations and uses thereof
    Patent number: 11951153
    Abstract: Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Grant
    Filed: September 26, 2022
    Date of Patent: April 9, 2024
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Sidney L. Weiss, Ashim K. Mitra, Eugene J. McNally
  • TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF
    Publication number: 20230083458
    Abstract: Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Application
    Filed: September 26, 2022
    Publication date: March 16, 2023
    Inventors: Sidney L. WEISS, Ashim K. MITRA, Eugene J. MCNALLY
  • TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF
    Publication number: 20210145924
    Abstract: Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Application
    Filed: January 7, 2021
    Publication date: May 20, 2021
    Inventors: Sidney L. WEISS, Ashim K. MITRA, Eugene J. MCNALLY
  • Topical cyclosporine-containing formulations and uses thereof
    Patent number: 10918694
    Abstract: Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: February 16, 2021
    Assignee: SUN PHARMA GLOBAL FZE
    Inventors: Sidney L. Weiss, Ashim K. Mitra, Eugene J. McNally
  • Topical formulations and uses thereof
    Patent number: 10441630
    Abstract: Provided herein include formulations for topical administration, such as ophthalmic formulations, and methods of using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and or a polyalkoxylated alcohol and may include nanomicelles. Also include methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: October 15, 2019
    Assignee: SUN PHARMA GLOBAL FZE
    Inventors: Ashim K. Mitra, Sidney L. Weiss, Eugene J. McNally
  • TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF
    Publication number: 20190060397
    Abstract: Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Application
    Filed: February 28, 2017
    Publication date: February 28, 2019
    Inventors: Sidney L. WEISS, Ashim K. MITRA, Eugene J. MCNALLY
  • TOPICAL FORMULATIONS AND USES THEREOF
    Publication number: 20160256521
    Abstract: Provided herein include formulations for topical administration, such as ophthalmic formulations, and methods of using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and or a polyalkoxylated alcohol and may include nanomicelles. Also include methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 8, 2016
    Applicant: OCULAR TECHNOLOGIES SARL
    Inventors: Ashim K. Mitra, Sidney L. WEISS, Eugene J. MCNALLY
  • TOPICAL FORMULATIONS AND USES THEREOF
    Publication number: 20150165048
    Abstract: Provided herein include formulations for topical administration, such as ophthalmic formulations, and methods of using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and or a polyalkoxylated alcohol and may include nanomicelles. Also include methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Ashim K. MITRA, Sidney L. WEISS, Eugene J. MCNALLY
  • Intercellular adhesion molecule powder formulation
    Patent number: 6365343
    Abstract: The present application discloses a finely divided, dry powdered pharmaceutical composition which is specially adapted to be administered as an insufflate which includes the following ingredients: (a) an pharmacologically effective amount of sICAM-1; (b) an amount of carboxymethyl cellulose which is effective to retain sICAM-1 on the intranasal membranes; (c) an amount of a bulking agent which is effective to provide a bulking effect without exerting a significant effect on the retention of the sICAM-1 on the nasal passages.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: April 2, 2002
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventor: Eugene J. McNally